Fenofibrate reduces the severity of neuroretinopathy in a type 2 model of diabetes without inducing peroxisome proliferator-activated receptor alpha-dependent retinal gene expression

Authors

Jennifer M Enright, Washington University School of Medicine in St. Louis
Sheng Zhang, Washington University School of Medicine in St. Louis
Christina Thebeau, Washington University School of Medicine in St. Louis
Emily Siebert, UT Southwestern Medical Center
Alexander Jin, Saint Louis University
Veda Gadiraju, University of Washington - Seattle Campus
Xiaodong Zhang, Washington University School of Medicine in St. Louis
Shiming Chen, Washington University School of Medicine in St. Louis
Clay F Semenkovich, Washington University School of Medicine in St. Louis
Rithwick Rajagopal, Washington University School of Medicine in St. Louis

Journal

Journal of Clinical Medicine

Publication Date

2020

Volume

10

Issue

1

First Page

126

Document Type

Open Access Publication

DOI

10.3390/jcm10010126

Rights and Permissions

Enright JM, Zhang S, Thebeau C, et al. Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression. J Clin Med. 2020;10(1):126. Published 2020 Dec 31. doi:10.3390/jcm10010126

Recommended Citation

Enright, Jennifer M; Zhang, Sheng; Thebeau, Christina; Siebert, Emily; Jin, Alexander; Gadiraju, Veda; Zhang, Xiaodong; Chen, Shiming; Semenkovich, Clay F; and Rajagopal, Rithwick, "Fenofibrate reduces the severity of neuroretinopathy in a type 2 model of diabetes without inducing peroxisome proliferator-activated receptor alpha-dependent retinal gene expression." Journal of Clinical Medicine. 10, 1. 126 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/10038